In addition, shareholders will receive
contingent value rights entitling them to pro rata proceeds relating to deferred consideration from the sale of PDC and any proceeds from the sale of Safeway's 49% interest in Casa Ley.
The transaction also covers
contingent value rights giving right to shares for an additional value of up to $55 million, based on the potential US Food and Drug Administration (FDA) approval(s) of AC-170 and two additional undisclosed products within a pre-determined period.
Additionally, the company said that since the terms for distribution of common shares to holders of its
Contingent Value Rights (CVRs) were not met as of the February 8, 2010 Measurement Date, they have expired without value.
ACLARA stockholders will own around 48% of the company and have
contingent value rights for potential cash payments.
Additionally, SCMF shareholders will receive non-transferable
contingent value rights entitling them to receive up to $1.
On October 6, 2014, WilmerHale client Durata Therapeutics announced that it had entered into a definitive merger agreement with Actavis plc under which a subsidiary of Actavis will commence a tender offer to acquire all of the outstanding shares of Durata common stock for $23 per share in cash, or approximately $675 million in the aggregate, and
contingent value rights entitling the holder to receive additional cash payments of up to $5 per share if certain regulatory or commercial milestones related to Durata's lead product DALVANCE are achieved.
00 in cash for each share of Durata common stock they own, as well as
contingent value rights entitling the holder to additional cash payments of up to $5.
00 in cash for each share of Durata stock they own, as well as
contingent value rights entitling the holder to receive additional cash payments of up to $5.
Aciex shareholders will receive an upfront payment of $65 million entirely in the form of 20,627,024 newly issued Nicox shares, plus
contingent value rights (CVRs) giving right to Nicox shares based on the potential FDA approval(s) of AC-170 and of two additional undisclosed products within a pre-determined period.
Subject to certain conditions, SCMF shareholders also will receive non-transferable
contingent value rights entitling them to receive up to $1.
According to Nicox, the agreement comprises a $65 million upfront payment in newly issued Nicox shares and
contingent value rights to shares that may raise the purchase total to a maximum of $120 million.
44 in cash per share and
contingent value rights that could pay up to $1.
